Immune System Diseases
Research at this site concentrates on immune system diseases, primarily targeting inflammatory bowel conditions such as ulcerative colitis and Crohn’s disease. The trials aim to evaluate the effectiveness of a novel therapy, duvakitug, for both induction and maintenance phases.
- Induction therapy for ulcerative colitis
- Maintenance therapy for ulcerative colitis
- Induction therapy for Crohn’s disease
- Maintenance therapy for Crohn’s disease
The Marienkrankenhaus Kassel gGmbH is conducting these studies to determine whether duvakitug can improve symptom control and reduce relapse rates for patients with moderate to severe disease.
